237 related articles for article (PubMed ID: 12451240)
21. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
22. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
[TBL] [Abstract][Full Text] [Related]
23. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
24. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
Cosimi AB; Sachs DH; Sykes M; Kawai T
Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
[TBL] [Abstract][Full Text] [Related]
25. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys.
Kimikawa M; Sachs DH; Colvin RB; Bartholomew A; Kawai T; Cosimi AB
Transplantation; 1997 Sep; 64(5):709-16. PubMed ID: 9311707
[TBL] [Abstract][Full Text] [Related]
26. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
Foster RD; Pham S; Li S; Aitouche A
Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
[TBL] [Abstract][Full Text] [Related]
27. Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.
Yamada Y; Ochiai T; Boskovic S; Nadazdin O; Oura T; Schoenfeld D; Cappetta K; Smith RN; Colvin RB; Madsen JC; Sachs DH; Benichou G; Cosimi AB; Kawai T
Am J Transplant; 2014 Dec; 14(12):2704-12. PubMed ID: 25394378
[TBL] [Abstract][Full Text] [Related]
28. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
[TBL] [Abstract][Full Text] [Related]
29. Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates.
Kawai T; Wee SL; Bazin H; Latinne D; Phelan J; Boskovic S; Ko DS; Hong HZ; Mauiyyedi S; Nadazdin O; Abrahamian G; Preffer F; Colvin RB; Sachs DH; Cosimi AB
Transplantation; 2000 Jul; 70(2):368-74. PubMed ID: 10933165
[TBL] [Abstract][Full Text] [Related]
30. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.
Leventhal J; Abecassis M; Miller J; Gallon L; Tollerud D; Elliott MJ; Bozulic LD; Houston C; Sustento-Reodica N; Ildstad ST
Transplantation; 2013 Jan; 95(1):169-76. PubMed ID: 23222893
[TBL] [Abstract][Full Text] [Related]
31. Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation: Protocol Optimization.
Lee KW; Park JB; Park H; Kwon Y; Lee JS; Kim KS; Chung YJ; Rhu JS; Choi S; Kwon GY; Kim HJ; Kang ES; Jung CW; Shin EC; Kawai T; Kim SJ; Joh JW
Transplantation; 2020 Jul; 104(7):1472-1482. PubMed ID: 31634324
[TBL] [Abstract][Full Text] [Related]
32. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.
Millan MT; Shizuru JA; Hoffmann P; Dejbakhsh-Jones S; Scandling JD; Grumet FC; Tan JC; Salvatierra O; Hoppe RT; Strober S
Transplantation; 2002 May; 73(9):1386-91. PubMed ID: 12023614
[TBL] [Abstract][Full Text] [Related]
33. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
[TBL] [Abstract][Full Text] [Related]
34. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
[TBL] [Abstract][Full Text] [Related]
35. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
[TBL] [Abstract][Full Text] [Related]
36. Variable relationship between chimerism and tolerance after hematopoietic cell transplantation without myelosuppressive conditioning.
Gleit ZL; Fuchimoto Y; Yamada K; Melendy E; Scheier-Dolberg R; Monajati L; Coburn RC; Neville DM; Sachs DH; Huang CA
Transplantation; 2002 Dec; 74(11):1535-44. PubMed ID: 12490786
[TBL] [Abstract][Full Text] [Related]
37. Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.
Fehr T; Hübel K; de Rougemont O; Abela I; Gaspert A; Güngör T; Hauri M; Helmchen B; Linsenmeier C; Müller T; Nilsson J; Riesterer O; Scandling JD; Schanz U; Cippà PE
Front Immunol; 2022; 13():796456. PubMed ID: 35173720
[TBL] [Abstract][Full Text] [Related]
38. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
Leventhal J; Abecassis M; Miller J; Gallon L; Ravindra K; Tollerud DJ; King B; Elliott MJ; Herzig G; Herzig R; Ildstad ST
Sci Transl Med; 2012 Mar; 4(124):124ra28. PubMed ID: 22399264
[TBL] [Abstract][Full Text] [Related]
39. Tolerance in a concordant nonhuman primate model.
Bartholomew AM; Powelson J; Sachs DH; Bailin M; Boskovic S; Colvin R; Hong HZ; Johnson M; Kimikawa M; LeGuern A; Meehan S; Sablinski T; Wee SL; Cosimi AB
Transplantation; 1999 Dec; 68(11):1708-16. PubMed ID: 10609947
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case report.
Wagner L; Lengyel L; Mikala G; Reményi P; Piros L; Csomor J; Fábry L; Tordai A; Langer RM; Masszi T
Transplant Proc; 2013; 45(10):3705-7. PubMed ID: 24315003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
